NO20032097L - Gj¶ravledet vaksine mot IPNV - Google Patents

Gj¶ravledet vaksine mot IPNV

Info

Publication number
NO20032097L
NO20032097L NO20032097A NO20032097A NO20032097L NO 20032097 L NO20032097 L NO 20032097L NO 20032097 A NO20032097 A NO 20032097A NO 20032097 A NO20032097 A NO 20032097A NO 20032097 L NO20032097 L NO 20032097L
Authority
NO
Norway
Prior art keywords
vaccines
ipnv
vaccine
polypeptide
disclosed
Prior art date
Application number
NO20032097A
Other languages
English (en)
Other versions
NO333007B1 (no
NO20032097D0 (no
Inventor
William Thomas Melvin
Suzanne Breeman
Marie Beagley Labus
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0027644A external-priority patent/GB0027644D0/en
Priority claimed from GB0030765A external-priority patent/GB0030765D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of NO20032097D0 publication Critical patent/NO20032097D0/no
Publication of NO20032097L publication Critical patent/NO20032097L/no
Publication of NO333007B1 publication Critical patent/NO333007B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20032097A 2000-11-11 2003-05-09 Fremgangsmate for a fremstille bivalent vaksine mot IPNV, ekspresjonsvektor, vertcelle og bivalent vaksine. NO333007B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0027644A GB0027644D0 (en) 2000-11-11 2000-11-11 Fish vaccine
GB0030765A GB0030765D0 (en) 2000-12-14 2000-12-14 Fish vaccine
PCT/GB2001/004986 WO2002038770A1 (en) 2000-11-11 2001-11-12 Yeast derived vaccine against ipnv

Publications (3)

Publication Number Publication Date
NO20032097D0 NO20032097D0 (no) 2003-05-09
NO20032097L true NO20032097L (no) 2003-07-10
NO333007B1 NO333007B1 (no) 2013-02-18

Family

ID=26245278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032097A NO333007B1 (no) 2000-11-11 2003-05-09 Fremgangsmate for a fremstille bivalent vaksine mot IPNV, ekspresjonsvektor, vertcelle og bivalent vaksine.

Country Status (8)

Country Link
EP (1) EP1334197B1 (no)
AT (1) ATE494377T1 (no)
AU (1) AU2002212555A1 (no)
CA (1) CA2428027C (no)
DE (1) DE60143810D1 (no)
DK (1) DK1334197T3 (no)
NO (1) NO333007B1 (no)
WO (1) WO2002038770A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008563A (es) * 2001-03-23 2005-03-07 Advanced Bionutrition Alimentos microbianos para acuacultural y agricultura.
TWI350310B (en) 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
AU2004279610B2 (en) * 2003-10-07 2010-02-25 Ingrid Dheur Piscirickettsia salmonis antigens and use thereof
EP1794185A1 (en) * 2004-10-01 2007-06-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof
WO2008140610A2 (en) 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
NZ578541A (en) * 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
AU2008337440B2 (en) 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
CA2885333C (en) 2012-09-26 2021-02-09 Fvg Limited Subunit immersion vaccines for fish
BR112019017853A2 (pt) 2017-02-28 2021-04-27 Vib Vzw Meios e métodos para liberação oral de proteína
CN115804837B (zh) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 一种传染性胰脏坏死病佐剂疫苗及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus

Also Published As

Publication number Publication date
EP1334197B1 (en) 2011-01-05
EP1334197A1 (en) 2003-08-13
CA2428027A1 (en) 2002-05-16
NO333007B1 (no) 2013-02-18
WO2002038770A1 (en) 2002-05-16
DK1334197T3 (da) 2011-04-04
ATE494377T1 (de) 2011-01-15
DE60143810D1 (de) 2011-02-17
NO20032097D0 (no) 2003-05-09
AU2002212555A1 (en) 2002-05-21
CA2428027C (en) 2012-09-11

Similar Documents

Publication Publication Date Title
EA200801221A1 (ru) Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк
MXPA05009096A (es) Metodo de cultivo celular libre de animal.
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
DK0633929T3 (da) Fremgangsmåde til in vitro proliferation af dendritcelleforstadier og deres anvendelse til at producere immunogener
WO2007024941A3 (en) Polyvalent vaccine
Loomis et al. Emerging vaccine technologies
ATE542891T1 (de) Verfahren zur herstellung von biologischen produkten in protein-freier kultur
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
NZ589755A (en) Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
EP1054683A4 (en) MODIFIED HEAT SHOCK PROTEIN / PEPTIDEANT COMPLEX
WO2006095330A3 (en) Methods and immunogenic cell preparations for treating antigen-associated diseases
CA2505942A1 (en) West nile virus vaccine
NO20032097D0 (no) Gj¶ravledet vaksine mot IPNV
NO20050396L (no) Adjuvant viral partikkel
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
Kong et al. Modulation of the immune response to the severe acute respiratory syndrome spike glycoprotein by gene-based and inactivated virus immunization
IL148741A0 (en) Vaccine
AR041515A1 (es) Vacuna a dna contra el virus de papiloma humano
CN101564533A (zh) 戊型肝炎蛋白-核酸复合疫苗及其制备方法
Shao et al. Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
WO2019139648A3 (en) Dna antibody constructs for use against ebola virus
WO2000058444A3 (en) Adaptation of virus to vertebrate cells

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees